Jaerang Rho
- Oncology top 1%
- Bone health and treatments 12
- Cytokine Signaling Pathways and Interactions 6
- Cancer Research top 2%
- NF-κB Signaling Pathways 10
- Molecular Biology top 2%
- Bone Metabolism and Diseases 24
- Cancer-related gene regulation 5
- Immunology top 2%
- Immune Response and Inflammation 7
-
- Cell Adhesion Molecules Research 8
-
- Virus-based gene therapy research 6
- Co-authors
- Yongwon ChoiNacksung KimDulshara Sachini AmarasekaraSoo Young LeeMasamichi TakamiSumi KimJoseph LorenzoBrian Wong
- Journals
- Journal of Biological Chemistry (7 papers)Angewandte Chemie International Edition (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Jaerang Rho
72 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 2.0k
- Orthopedics and Sports Medicine 596
- Cancer Research 962
- Molecular Biology 3.7k
- Immunology 1.1k
Countries citing papers authored by Jaerang Rho
This map shows the geographic impact of Jaerang Rho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaerang Rho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaerang Rho more than expected).
Fields of papers citing papers by Jaerang Rho
This network shows the impact of papers produced by Jaerang Rho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaerang Rho. The network helps show where Jaerang Rho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jaerang Rho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 5 | |
| 5 | 2019 | 12 | |
| 6 | 2015 | 51 | |
| 7 | 2012 | 44 | |
| 8 | 2011 | 21 | |
| 9 | 2011 | 6 | |
| 10 | 2009 | 23 | |
| 11 | 2008 | 73 | |
| 12 | 2006 | 450 | |
| 13 | 2005 | 161 | |
| 14 | 2003 | 82 | |
| 15 | 2002 | 53 | |
| 16 | 2001 | 121 | |
| 17 | Adenovirus-mediated mGM-CSF in vivo Gene Transfer Inhibits Tumor Growth in a Murine Meth A Fibrosarcoma Model | 2000 | 1 |
| 18 | 1997 | 2 | |
| 19 | TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cellsbreakdown → | 1997 | 880 |
| 20 | 1994 | 22 |
About Jaerang Rho
Jaerang Rho is a scholar working on Immunology and Allergy, Immunology and Cancer Research, having authored 74 papers that have together received 5.3k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (24 papers), Bone health and treatments (12 papers), NF-κB Signaling Pathways (10 papers), Cell Adhesion Molecules Research (8 papers), Immune Response and Inflammation (7 papers), Cytokine Signaling Pathways and Interactions (6 papers), Virus-based gene therapy research (6 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Oncology (2.0k citations), Orthopedics and Sports Medicine (596 citations) and Cancer Research (962 citations). Jaerang Rho has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Yongwon Choi, Nacksung Kim, Dulshara Sachini Amarasekara, Soo Young Lee, Masamichi Takami, Sumi Kim, Joseph Lorenzo, Brian Wong, Daewon Jeong and Matthew C. Walsh. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.